Family-Ordered Report Finds Cocaine, Propofol in Late Singer’s Blood
Cocaine, propofol, and midazolam sit among an eight-substance cocktail discovered in the bloodstream of late Greek singer Giorgos Mazonakis, according to a toxicological report ordered by the artist’s family.
Laboratory Analysis Details Eight Specific Compounds
The analysis, conducted in a laboratory in Netherlands, identified a total of eight distinct substances. Expert Giorgos Ficialos presented the data.
The list includes cocaine, benzoylecgonine, propofol, midazolam, flumazenil, lidocaine, olanzapine, and aripiprazole.
Propofol and Midazolam Used for Sedation
Propofol and midazolam draw particular attention as medications utilized in medical sedation and anesthesia. Flumazenil serves as an antidote designed to counter the effects of benzodiazepines such as midazolam.
Varying Media Focus on Quantities and Cause
Final conclusions depend on concentrations, interactions, and the complete forensic examination.
Three Distinct Phases Outlined by Experts
Ficialos described the combination of sedatives as explosive for the human organism.

The findings suggest three distinct phases in the progression leading to the singer’s death: the administration of sedatives, the subsequent deterioration of clinical status, and an attempted reversal of the situation.
Doctors Face Homicide Charges After Singer Dies
The 54-year-old singer died while undergoing plasmapheresis, a procedure where blood plasma is removed, filtered, and returned to the body.
Two doctors were placed under detention in September and face charges of homicide with eventual intent by omission, as reported by eKathimerini. The defense has denied wrongdoing and attributed responsibility to emergency medical response teams.
The completed toxicological report now awaits formal presentation to the investigator handling the case. Final determinations on the cause of death remain dependent on the evaluation of substance concentrations and subsequent rulings from the forensic medical service in Athens.
Keep reading